Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wilken

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|May 3, 2003
Stapled versus excision haemorrhoidectomy: long-term follow up of a randomised controlled trialEdward F Smyth, Richard P Baker, Bert J Wilken, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 17, 2001
Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domainL A Marcaurelle, L S Mizoue, J Wilken, et al.
FEBS Letters|January 7, 1999
Accessibility of selenomethionine proteins by total chemical synthesis: structural studies of human herpesvirus-8 MIP-IIW Shao, E Fernandez, J Wilken, et al.
The Joint Commission Journal on Quality Improvement|September 10, 2002
A rapid interview protocol supporting patient-centered quality improvement: hearing the parent's voice in a pediatric cancer unitElisa J Sobo, Glenn Billman, Lillian Lim, et al.
Molecular Endocrinology (Baltimore, Md.)|January 19, 1999
Characterization of Agouti-related protein binding to melanocortin receptorsY K Yang, D A Thompson, C J Dickinson, et al.
Genes & Development|July 18, 2000
Sexual dimorphism in diverse metazoans is regulated by a novel class of intertwined zinc fingersL Zhu, J Wilken, N B Phillips, et al.
Chemistry & Biology|January 16, 1999
Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTESJ Wilken, D Hoover, D A Thompson, et al.
FEBS Letters|June 17, 1999
NMR structure of a minimized human agouti related protein prepared by total chemical synthesisK A Bolin, D J Anderson, J A Trulson, et al.
Journal of Virology|April 10, 1999
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variantsD E Mosier, G R Picchio, R J Gulizia, et al.
AIDS Research and Human Retroviruses|July 17, 1999
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferationS Rusconi, S La Seta-Catamancio, S Kurtagic, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|May 3, 2003
Stapled versus excision haemorrhoidectomy: long-term follow up of a randomised controlled trialEdward F Smyth, Richard P Baker, Bert J Wilken, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 17, 2001
Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domainL A Marcaurelle, L S Mizoue, J Wilken, et al.
FEBS Letters|January 7, 1999
Accessibility of selenomethionine proteins by total chemical synthesis: structural studies of human herpesvirus-8 MIP-IIW Shao, E Fernandez, J Wilken, et al.
The Joint Commission Journal on Quality Improvement|September 10, 2002
A rapid interview protocol supporting patient-centered quality improvement: hearing the parent's voice in a pediatric cancer unitElisa J Sobo, Glenn Billman, Lillian Lim, et al.
Molecular Endocrinology (Baltimore, Md.)|January 19, 1999
Characterization of Agouti-related protein binding to melanocortin receptorsY K Yang, D A Thompson, C J Dickinson, et al.
Genes & Development|July 18, 2000
Sexual dimorphism in diverse metazoans is regulated by a novel class of intertwined zinc fingersL Zhu, J Wilken, N B Phillips, et al.
Chemistry & Biology|January 16, 1999
Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTESJ Wilken, D Hoover, D A Thompson, et al.
FEBS Letters|June 17, 1999
NMR structure of a minimized human agouti related protein prepared by total chemical synthesisK A Bolin, D J Anderson, J A Trulson, et al.
Journal of Virology|April 10, 1999
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variantsD E Mosier, G R Picchio, R J Gulizia, et al.
AIDS Research and Human Retroviruses|July 17, 1999
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferationS Rusconi, S La Seta-Catamancio, S Kurtagic, et al.
Pageof 5